Kikkoman Corporation provided consolidated earnings guidance for the year 2023. For the year, the company expects Revenue of JPY 596,700 million, Operating profit of JPY 52,800 million, profit attributable to owners of parent JPY 40,700 million and basic earnings per share of JPY 212.53.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,958 JPY | +1.01% | +5.21% | +13.39% |
Feb. 29 | Riken Vitamin, Kikkoman End Raw Materials Partnership | MT |
Feb. 29 | Tranche Update on Riken Vitamin Co., Ltd.'s Equity Buyback Plan announced on February 28, 2024. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.39% | 11.86B | |
+0.29% | 29.21B | |
+4.16% | 21.53B | |
+12.98% | 5.17B | |
+9.95% | 4.17B | |
-18.33% | 3.4B | |
-2.86% | 3.15B | |
+3.67% | 3.08B | |
+27.19% | 2.79B | |
+0.80% | 2.31B |
- Stock Market
- Equities
- 2801 Stock
- News Kikkoman Corporation
- Kikkoman Corporation Provides Consolidated Earnings Guidance for the Year 2023